Yttrium (90Y) tacatuzumab tetraxetan

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Yttrium (90Y) tacatuzumab tetraxetan
Y-90 tacatuzumab tetraxetan structure.svg
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target α-fetoprotein
Clinical data
ATC code
  • none
CAS Number
  • none
Chemical and physical data
Formula C6470H9971N1712O2007S4290Y
Molar mass 145 kg/mol
 NYesY (what is this?)  (verify)

Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.